Cholangiocarcinoma News and Research

RSS
ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

Washington University School of Medicine receives $17 million to address disparities in cancers

Washington University School of Medicine receives $17 million to address disparities in cancers

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Study identifies actionable genes and candidate drugs in biliary tract cancer using a knowledgebase

Study identifies actionable genes and candidate drugs in biliary tract cancer using a knowledgebase

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

AMSBIO's custom lentivectors for labeling organoids

AMSBIO's custom lentivectors for labeling organoids

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

AACR and MPM award three grants to support groundbreaking cancer research projects

AACR and MPM award three grants to support groundbreaking cancer research projects

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

Researchers discover a new approach to inhibit intrahepatic cholangiocarcinoma

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study